Therapeutic Area
Company / Innovator
News & Updates

Reach us
nhs@noelgenomics.com

Therapeutic Area
Company / Innovator
News & Updates

nhs@noelgenomics.com

Search for:

News & Updates

B-Cell Precursor ALL Bristol Myers Squibb Congenital Athymia Deep Partial-Thickness Burns Dendreon Corporation Diffuse Large B-Cell Lymphoma Enzyvant Therapeutics Gilead Sciences Large B-Cell Lymphoma Mantle Cell Lymphoma Metastatic Castration-Resistant Prostate Cancer Multiple Myeloma Novartis International Retinal Dystrophy Spinal Muscular Atrophy Stratatech Corporation

Featured Posts

ABECMA (idecabtagene vicleucel) – CAR T Cell Therapy by Bristol Myers Squibb (BMS)
BREYANZI (lisocabtagene maraleucel) – CAR T Cell Therapy by Bristol Myers Squibb (BMS)
TECARTUS (brexucabtagene autoleucel) – CAR T Cell Therapy by Gilead Sciences
YESCARTA (axicabtagene ciloleucel) – CAR T Cell Therapy by Gilead Sciences
KYMRIAH (tisagenlecleucel) – CAR T Cell Therapy by Novartis Pharmaceuticals

Recent Posts

PROVENGE (Sipuleucel-T) – Cellular Immunotherapy by Dendreon Corporation
- November 14, 2021
STRATAGRAFT (allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen-dsat) – by Stratatech Corporation
- November 14, 2021
LUXTURNA (voretigene neparvovec-rzyl) – Gene Therapy by Spark Therapeutics
- November 14, 2021

Therapeutic Area
Company / Innovator
News & Updates

Facebook Twitter Linkedin

All the information and updates compiled based on the officially published content for the benifit of patients and health care providers. Copyrights for any product or brand mentioned or referred to belong to the respective innovators and licensed companies. Factual information shared for general awareness purpose only. No copyright infringement intended in any manner.

© 2021 – 2022 Noel Health. All Rights Reserved